Cancer Research
Strength Training Fights Inflammaging in Bone Marrow Transplant Survivors
A 10-week supervised strength program targets chronic inflammation and self-efficacy in long-term allogeneic HCT survivors.
Clinical Trial
May 25, 2026 0
Results for "Klotho Protein" in Cancer
20 articles
Cancer Research
Physical Therapy and Relaxation Techniques Boost Resilience in Older Lung Cancer Patients
A completed pilot trial tested physical therapy and progressive muscle relaxation to preserve function and mood in older adults with advanced lung cancer.
Clinical Trial
May 12, 2026 0
Cancer Research
12-Week Exercise Program Targets Body Composition in Breast Cancer Survivors
A completed trial examines how structured exercise reshapes body composition and sustains physical activity habits in breast cancer patients post-diagnosis.
Clinical Trial
Jun 17, 2026 0
Cancer Research
MOBIDERM Compression Panty Tested for Pelvic and Genital Lymphedema Relief
A completed exploratory trial evaluates whether a specialized compression garment can reduce discomfort and improve quality of life in pelvic lymphedema patients.
Clinical Trial
Jun 14, 2026 0
Cancer Research
CD226 Immune Receptor Explored as Predictor of Immunotherapy Response in Advanced Liver Cancer
A French trial investigated whether circulating immune cell profiles, specifically CD226 expression, could predict who responds to Atezolizumab/Bevacizumab in advanced HCC.
Clinical Trial
Jun 9, 2026 0
Cancer Research
New Cancer Drug NKTR-255 Shows Promise in Blood Cancer Treatment Trial
Phase 1 trial tests innovative immunotherapy for multiple myeloma and lymphoma patients who didn't respond to standard treatments.
Clinical Trial
Mar 29, 2026 1
Cancer Research
Natural Killer Cell Therapy Shows Promise for Advanced Cancer Treatment
Autologous NK cell therapy combined with immunotherapy tested in 27 patients with treatment-resistant cancers.
Clinical Trial
Mar 29, 2026 0
Cancer Research
Liquid Biopsy for Sarcoma: Can cfDNA and Telomere Mutations Predict Recurrence
Researchers explored whether cancer-derived cell-free DNA and telomere maintenance mutations could serve as early warning biomarkers in soft tissue sarcoma patients.
Clinical Trial
May 16, 2026 0
Cancer Research
Liquid Biopsy Guides Targeted Lung Cancer Treatment in Breakthrough Trial
New study shows how analyzing fluid from lungs can detect cancer mutations and guide personalized treatment decisions.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Melanoma Drug Resistance Linked to Cellular Communication Vesicles Called Exosomes
French researchers studied how tiny cellular packages called exosomes may help melanoma cells resist treatment and spread throughout the body.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Wearable Sensors Track Cancer Therapy Side Effects in Real-Time Stanford Study
Stanford researchers used smartwatches and blood tests to monitor dangerous side effects during cutting-edge CAR-T cancer treatment.
Clinical Trial
Mar 29, 2026 1
Cancer Research
Skin Microbiome Shifts Detected in Immunotherapy Rash Patients
A City of Hope study explores whether skin bacteria differ between rash-affected and healthy skin in cancer immunotherapy patients.
Clinical Trial
Jun 6, 2026 0
Cancer Research
Blood Test Detects Hidden Cancer Cells After Colorectal Surgery Using Exosomes
New liquid biopsy technique identifies molecular residual disease in colorectal cancer patients to guide personalized treatment decisions.
Clinical Trial
Mar 28, 2026 1
Cancer Research
L-Arginine Tested to Restore Erectile Function in Prostate Cancer Radiation Survivors
A phase II trial explores whether the amino acid L-arginine, with or without enzyme inhibitors, can improve erectile function and quality of life after prostate cancer radiation therapy.
Clinical Trial
May 29, 2026 0
Cancer Research
Time-Restricted Eating Shows Promise for Breast Cancer Survivors Over 60
Eight-week study of weekday-only intermittent fasting in older breast cancer survivors with overweight demonstrates feasibility.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Trial Tests Whether Stopping Immunotherapy Early Harms NSCLC Patients Who Respond
A randomized Phase 2 trial investigates whether PD-1 inhibitor discontinuation after early response is safe in non-small cell lung cancer.
Clinical Trial
Jun 14, 2026 0
Cancer Research
16-Week Holistic Program Boosts Quality of Life in Cancer Survivors
A pilot trial tested a comprehensive physical, mental, and spiritual intervention for cancer survivors, tracking outcomes at 6 months post-program.
Clinical Trial
May 28, 2026 0
Cancer Research
Engineered Immune Cells Show Promise Against Advanced Cancer in Early Trial
Scientists modified patients' immune cells to better recognize and attack cancer tumors expressing NY-ESO-1 protein.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Triple Immune Checkpoint Blockade Tested in Advanced Solid Tumors
A Phase 1/2 trial explores combining KIR, PD-1, and CTLA-4 inhibitors to unlock stronger anti-tumor immunity.
Clinical Trial
May 20, 2026 0
Cancer Research
Low-Dose Gut Radiation Revives Immune Checkpoint Therapy in Drug-Resistant Cancers
A phase II trial tests whether 1Gy intestinal radiation can re-sensitize solid tumors that have stopped responding to immunotherapy.
Clinical Trial
Jul 1, 2026 0
Page 1 of 2Next